Search alternatives:
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 821 - 840 results of 18,101 for search 'significantly ((((largest decrease) OR (greater decrease))) OR (((nn decrease) OR (a decrease))))', query time: 0.71s Refine Results
  1. 821
    Relationship between cigarettes per day and hazard ratio (HR) for CVD and mortality outcomes: a cubic spline model evaluation.

    Relationship between cigarettes per day and hazard ratio (HR) for CVD and mortality outcomes: a cubic spline model evaluation. by Erfan Tasdighi (9144667)

    Published 2025
    Save to List
    Saved in:
  2. 822
    Average contact force and percentage of strong contact force under different conditions: (a) different particle shapes, (b) different particle sizes.

    Average contact force and percentage of strong contact force under different conditions: (a) different particle shapes, (b) different particle sizes. by Yongfeng Zhu (7361045)

    Published 2025
    Save to List
    Saved in:
  3. 823
    Table 3_Increasing plasma ketamine concentrations decrease the minimum alveolar concentration of isoflurane in rabbits.docx

    Table 3_Increasing plasma ketamine concentrations decrease the minimum alveolar concentration of isoflurane in rabbits.docx by Linda S. Barter (21466916)

    Published 2025
    Save to List
    Saved in:
  4. 824
    Image 2_Increasing plasma ketamine concentrations decrease the minimum alveolar concentration of isoflurane in rabbits.jpeg

    Image 2_Increasing plasma ketamine concentrations decrease the minimum alveolar concentration of isoflurane in rabbits.jpeg by Linda S. Barter (21466916)

    Published 2025
    Save to List
    Saved in:
  5. 825
    Image 1_Increasing plasma ketamine concentrations decrease the minimum alveolar concentration of isoflurane in rabbits.jpeg

    Image 1_Increasing plasma ketamine concentrations decrease the minimum alveolar concentration of isoflurane in rabbits.jpeg by Linda S. Barter (21466916)

    Published 2025
    Save to List
    Saved in:
  6. 826
    Additional file 6 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study

    Additional file 6 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

    Published 2025
    Save to List
    Saved in:
  7. 827
    Additional file 9 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study

    Additional file 9 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

    Published 2025
    Save to List
    Saved in:
  8. 828
    Additional file 8 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study

    Additional file 8 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

    Published 2025
    Save to List
    Saved in:
  9. 829
    Additional file 7 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study

    Additional file 7 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

    Published 2025
    Save to List
    Saved in:
  10. 830
    Additional file 11 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study

    Additional file 11 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

    Published 2025
    Save to List
    Saved in:
  11. 831
    Additional file 10 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study

    Additional file 10 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

    Published 2025
    Save to List
    Saved in:
  12. 832
    Additional file 3 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study

    Additional file 3 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

    Published 2025
    Save to List
    Saved in:
  13. 833
    Disruption of the <i>pcnB</i> gene encoding poly(A) polymerase PAP I decreases pYV PCN as well as T3SS expression and activity.

    Disruption of the <i>pcnB</i> gene encoding poly(A) polymerase PAP I decreases pYV PCN as well as T3SS expression and activity. by Katherine Schubert (5452712)

    Published 2025
    Save to List
    Saved in:
  14. 834
    Supplementary file 1_Global variation in antibiotic prescribing guidelines and the implications for decreasing AMR in the future.docx

    Supplementary file 1_Global variation in antibiotic prescribing guidelines and the implications for decreasing AMR in the future.docx by Emmama Jamil (22005635)

    Published 2025
    Save to List
    Saved in:
  15. 835
    The influence of <i>PINK1</i> on <i>P</i>. <i>berghei</i> infection in <i>A</i>. <i>stephensi</i>.

    The influence of <i>PINK1</i> on <i>P</i>. <i>berghei</i> infection in <i>A</i>. <i>stephensi</i>. by Li Gao (131516)

    Published 2024
    Save to List
    Saved in:
  16. 836
    RipU<sup>K60</sup> decreases microtubule abundance at 48 hours post infiltration.

    RipU<sup>K60</sup> decreases microtubule abundance at 48 hours post infiltration. by Rachel Hiles (20477573)

    Published 2024
    “…(B) Heterologous expression of RipU<sup>K60</sup> significantly decreased microtubule number compared to controls at 48 hpi in <i>N</i>. …”
    Save to List
    Saved in:
  17. 837
    Change in Watt’s Connectedness Scale, Subscales by Treatment Group.

    Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 838
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 839
    Demographic and clinical characteristics of participants at baseline.

    Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 840
    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group.

    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: